The impact of uterine curettage postpartum on maternal sFlt-1 concentration

Journal of Perinatal Medicine

Volumn 44, Issue 3, 2016, Pages 351-354

  Ossada, Victoria ^a   Jank, Alexander ^a   Stepan, Holger ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Angiogenic factors; placental removal; preeclampsia

Indexed keywords

ANGIOGENIC FACTOR; VASCULOTROPIN RECEPTOR 1; BIOLOGICAL MARKER; FLT1 PROTEIN, HUMAN;

ADULT; ARTICLE; CESAREAN SECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CURETTAGE; FEMALE; GESTATIONAL AGE; HUMAN; MATERNAL AGE; MATERNAL BLOOD; PREECLAMPSIA; PRIMIGRAVIDA; PRIORITY JOURNAL; PUERPERIUM; SEIZURE; SERODIAGNOSIS; UTERUS SURGERY; BLOOD; CASE CONTROL STUDY; DILATATION AND CURETTAGE; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDY;

BIOMARKERS; CASE-CONTROL STUDIES; CESAREAN SECTION; DILATATION AND CURETTAGE; FEMALE; HUMANS; POSTPARTUM PERIOD; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84969677330     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/jpm-2015-0104     Document Type: Article

References (17)

1. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33:130-7.
2. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371:75-84.
3. World Health Organization. The World Health Report 2005 Make every mother and child count. 2014. Available at: http://www.who.int/whr/2005/en/.
4. Hagmann H, Thadhani R, Benzing T, Karumanchi SA, Stepan H. The promise of angiogenic markers for the early diagnosis and prediction of preeclampsia. Clin Chem. 2012;58:837-45.
5. Verlohren S, Stepan H, Dechend R. Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia. Clin Sci (Lond). 2012;122:43-52.
6. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355:992-1005.
7. Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med. 2008;21:9-23.
8. Stepan H, Schaarschmidt W, Jank A, Verlohren S, Kratzsch J. Use of angiogenic factors (sFlt-1/PlGF ratio) to confirm the diagnosis of preeclampsia in clinical routine: first experience. Z Geburtshilfe Neonatol. 2010;214:234-8.
9. Thadhani R, Mutter WP, Wolf M, Levine RJ, Taylor RN, Sukhatme VP, et al. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab. 2004;89:770-5.
10. Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler H, et al. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol. 2012;206:58.e1.
11. Magann EF, Martin JN Jr, Isaacs JD, Perry KG Jr, Martin RW, Meydrech EF. Immediate postpartum curettage: accelerated recovery from severe preeclampsia. Obstet Gynecol. 1993;81:502-6.
12. Matsuo K, Kooshesh S, Dinc M, Sun C, Kimura T, Baschat A. Late postpartum eclampsia: report of two cases managed by uterine curettage and review of the literature. Amer J Perinatol. 2007;24:257-66.
13. Alkan A, Tugrul S, Oral O, Uslu H, Kose D, Catakli FT. Effects of postpartum uterine curettage on maternal well-being in severe preeclamptic patients. Clin Exp Obstet Gynecol. 2006;33:55-8.
14. Magann EF, Bass D, Chauhan SP, Perry KG, Morrisin JC, Martin JN. Accelerated recovery from severe preeclampsia-uterine curettage versus nifedipine. J Soc Gynecol Investing. 1994;1:210-4
15. Ragab A, Goda H, Raghib M, Barakat R, El-Samanoudy A, Badawy A. Does immediate postpartum curettage of the endometrium accelerate recovery from preeclampsia-eclampsia? A randomized controlled trial. Arch Gynecol Obstet. 2013;288:1035-8.
16. Schlenzig C, Maurer S, Goppelt M, Ulm K, Kolben M. Postpartum curettage in patients with HELLP-syndrome does not result in accelerated recovery. Eur J Obstet Gynecol Reprod Biol. 2000;91:25-8.
17. Hupuczi P, Sziller I, Hruby E, Rigo B, Szabo G, Papp Z. The rate of maternal complications in 107 pregnancies complicated with HELLP syndrome. Orv Hetil. 2006;147:1377-85.